​

Synaptogenix Ownership | Who Owns Synaptogenix?

OverviewFinancialsChart

Synaptogenix Ownership Summary

Synaptogenix is owned by 93.21% institutional investors, and 6.79% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of SNPX shares. Fidelity Extended Market Index is the top mutual fund, with 0.51% of its assets in Synaptogenix shares.

SNPX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSynaptogenix93.21%-6.79%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Renaissance---
Blackrock---
Tower research capital llc (trc)---
Two sigma securities---
Advisor group---
Elevated capital advisors---
Hayek kallen investment management---
State street---
Saxony capital management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Renaissance---
Blackrock---
Tower research capital llc (trc)---
Two sigma securities---
Advisor group---
Elevated capital advisors---
Hayek kallen investment management---
State street---
Saxony capital management---

Top Buyers

HolderShares% AssetsChange
Tower research capital llc (trc)---102.00
Wells fargo & company/mn---159.00
Newbridge financial services group---300.00
Blackrock---732.00
Orion capital management---2.00K

Top Sellers

HolderShares% AssetsChange
Renaissance---401.10K
Geode capital management---154.47K
Citadel advisors---83.54K
Two sigma securities---83.41K
Vanguard group---68.52K

Sold Out

HolderChange
Tower research capital llc (trc)-102.00
Wells fargo & company/mn-159.00
Newbridge financial services group-300.00
Blackrock-732.00
Orion capital management-2.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202418-21.74%898,191-15.16%9395.26%6-53.85%350.00%
Dec 31, 2023239.52%1,058,714238.52%954.80%1330.00%2-60.00%
Sep 30, 20232140.00%312,74852.48%456.83%10100.00%5150.00%
Jun 30, 202315-11.76%205,108-21.81%222.36%5-28.57%2-33.33%
Mar 31, 202317-262,307-40.63%38.75%7-22.22%3-40.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index6.89K0.51%-44.00
Vanguard Institutional Extnd Mkt Idx Tr2.74K0.20%-
Fidelity Total Market Index1.93K0.14%-
Fidelity Series Total Market Index1.75K0.13%-
Fidelity Nasdaq Composite Index200.000.01%-
Northern Trust Extended Eq Market Idx189.000.01%-
NT Ext Equity Mkt Idx Fd - L189.000.01%-
NT Ext Equity Mkt Idx Fd - NL161.000.01%-
Spartan Extended Market Index Pool E150.000.01%44.00
Spartan Extended Market Index Pool F150.000.01%44.00

Insider Transactions Trends

DateBuySell
2024 Q2--
2023 Q1--
2022 Q4-7
2022 Q2--
2022 Q1--

SNPX Ownership FAQ

Who Owns Synaptogenix?

Synaptogenix shareholders are primarily institutional investors at 93.21%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Synaptogenix's industry, Biotech Stocks , is 68.48%, which Synaptogenix exceeds.

Who owns the most shares of Synaptogenix?

Synaptogenix’s largest shareholders are Geode capital management (0 shares, 0%), Renaissance (0 shares, 0%), and Blackrock (0 shares, 0%). Together, they hold 0% of Synaptogenix’s total shares outstanding.

Does Blackrock own Synaptogenix?

Yes, BlackRock owns 0% of Synaptogenix, totaling 0 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 0$. In the last quarter, BlackRock decreased its holdings by -732 shares, a -100.00% change.

Who is Synaptogenix’s biggest shareholder by percentage of total assets invested?

Geode capital management is Synaptogenix’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Synaptogenix shares, valued at 0$.

Who is the top mutual fund holder of Synaptogenix shares?

Fidelity Extended Market Index is the top mutual fund holder of Synaptogenix shares, with 0.51% of its total shares outstanding invested in 6.89K Synaptogenix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools